Список использованной литературы
Список использованной литературы
таблетки для приема один раз в день
Зитига
абиратерона ацетат
9.Heidenreich A с соавт. Guidelines on prostate cancer. European Association of Urology 2012. http://www.uroweb.org/gls/pdf/ 08%20Prostate%20Cancer_LR%20March%2013th%202012.pdf. Получено в августе 2012 г. [загрузить PDF]
10.ZYTIGA® Clinical Summary. Data on file. March 2012. Available upon request: [для вставки местной производящей организацией].
11.de Bono J с соавт. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011; 364: pl995-2005. (Дополнительное приложение), [загрузить PDF]
12.Sonpavde G с соавт. The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature. Eur Urol 2011; 60(2): p270-278. [загрузить PDF]
13.Harland S с соавт. Abiraterone acetate improves functional status in patients with metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel: results from the COU-AA-301 phase 3 study. Abstract presented at The European Multidisciplinary Cancer Congress; 2011; September23-27: Stockholm, Sweden, [загрузить PDF]
14.Sternberg С с соавт. Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy. Ann Oncol 2012; Epub Ahead of Print, [загрузить PDF]
15.Ryan С с соавт. Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med 2013; 368(2): p138-148 (Supplementary Appendix), [загрузить PDF]
16.Basch E с соавт. The impact of abiraterone acetate therapy on patient-reported pain and functional status in chemotherapy-naive patients with progressive, metastatic castration-resistant prostate cancer. Oral presentation at the ESMO 2012 Congress; 2012; Sept 28 - Oct 2; Vienna, Austria. Available on request: [local contact details to be inserted], [загрузить PDF]
|
